Doctors and the health industry: A case study of transcutaneous oxygen monitoring in neonatal intensive care

Social Science and Medicine

Volumn 42, Issue 9, 1996, Pages 1247-1258

  Miké, Valerie ^a   Krauss, Alfred N ^a   Ross, Gail S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Health industry; Oxygen monitoring; Premature infants; Technology assessment

Indexed keywords

ARTICLE; BLINDNESS; EYE DISEASE; HEALTH CARE; HEALTH CARE PERSONNEL; HUMAN; INTERVIEW; NEWBORN; NEWBORN INTENSIVE CARE; PREMATURITY; PULSE OXIMETRY; RETROLENTAL FIBROPLASIA; TECHNOLOGY; TRAINING; TRANSCUTANEOUS OXYGEN MONITORING; UNITED STATES;

EID: 0029921810     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/0277-9536(95)00222-7     Document Type: Article

References (51)

1. Miké V., Krauss A. N. and Ross G. S. Reflections on a medical innovation: transcutaneous oxygen monitoring in neonatal intensive care. Technol. Cult. 34, 894, 1993.
2. Yin R. K. Case Study Research: Design and Methods. Sage Publications, Beverly Hills, CA, 1984.
3. Health Devices Sourcebook, A Directory of Medical Devices, Trade Names and Manufacturers. ECRI (Emergency Care Research Institute), Plymouth Meeting, PA, 1989.
4. Medical Device Register, The Official Directory of Hospital Suppliers. Directory Systems, Inc., Greenwich, CT, 1989.
5. The Wilkerson Group (formerly Channing, Weinberg & Co., Inc.). Biochemical Monitoring: a Strategic Business Assessment. New York, 1987.
6. Kessler M., Bruley D. F., Clark L. C., Lübbers D. W., Silver I. A. and Strauss J. (Eds) Oxygen Supply: Theoretical and Practical Aspects of Oxygen Supply and Microcirculation of Tissue. Urban & Schwarzenberg, Munich, 1973.
7. Bruley D. F. The Birth of ISOTT. In Oxygen Transport to Tissue XI. Advances in Experimental Medicine and Biology (Edited by Rakusan K., Biro G. P., Goldstick T. K. and Turek Z.), Vol. 248, pp. xi-xiii. Plenum Press, New York, 1988.
8. Clark L. C. Monitor and control of blood and tissue oxygen tensions. Trans. Am. Soc. Art. Int. Organs 2, 41, 1956.
9. Huch R., Lübbers D. W. and Huch A. Quantitative continuous measurement of partial oxygen pressure on the skin of adults and new-born babies. Pflügers Arch. Eur. J. Physiol. 337, 185, 1972.
10. 2. Thieme-Stratton, New York, 1981.
11. Eberhard P., Hammacher K. and Mindt W. Methode zur kutanen Messung des Sauerstoffpartialdruckes. Biomediz. Technik 18, 216, 1973.
12. 2 and simultaneous control of relative local perfusion. In Oxygen Transport to Tissue. Advances in Experimental Medicine and Biology (Edited by Bruley D. F. and Bicher H. I.), Vol. 37B, pp. 1121-1127. Plenum Press, New York, 1973.
13. Clark L. C. Oxygen is like love. In Continuous Transcutaneous Blood Gas Monitoring (Edited by Huch A., Huch R. and Lucey J. F.), The National Foundation - March of Dimes Birth Defects: Original Article Series Vol. XV, Number 4, pp. 33-35. Alan R. Liss, New York, 1979.
14. 2): method and application in perinatal medicine. J. Perinatal. Med. 1, 183, 1973.
15. Huch A., Huch R. and Lucey J. F. (Eds) Continuous Transcutaneous Blood Gas Monitoring, The National Foundation - March of Dimes Birth Defects: Original Article Series Vol. XV, Number 4. Alan R. Liss, New York, 1979.
16. Huch R. and Huch A. (Eds) Continuous Transcutaneous Blood Gas Monitoring. Marcel Dekker, New York, 1983.
17. Huch A., Huch R. and Rooth G. (Eds) Continuous Transcutaneous Monitoring. Advances in Experimental Medicine and Biology, Vol. 220. Plenum Press, New York, 1987.
18. 2) monitoring: technology diffusion in neonatal medicine (Abstract). Pediatric Res. 27, 123A, 1990.
19. Food and Drug Administration. Regulatory Requirements for Medical Devices, 3rd edn (FDA 85-4165). U.S. Government Printing Office, Washington, DC, 1985.
20. Gluck M. S. and Hlavinka L. E. Cutaneous gas monitors. J. Clin. Monitoring 2, 74, 1986.
21. Product Development Directory, An Historical Index to FDA 510(k) Filings by Product Category. From Medical Device Register. Directory Systems, Inc., Greenwich, CT, 1988.
22. The Wilkerson Group (formerly Channing, Weinberg & Co., Inc.). Opportunities in Transcutaneous, Blood Gas, and Electrolyte Monitoring. The Wilkerson Group, New York, 1982.
23. Terry T. L. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. I. Preliminary report. Am. J. Ophthalmol. 25, 203, 1942.
24. Silverman W. A. Retrolental Fibroplasia: A Modern Parable. Grune & Stratton, New York, 1980.
25. Lanman J. T., Guy L. P. and Dancis J. Retrolental fibroplasia and oxygen therapy. J. Am. Med. Assoc. 155, 223, 1954.
26. Kinsey V. E. Retrolental fibroplasia: cooperative study of retrolental fibroplasia and the use of oxygen. AMA Arch. Ophthalmol. 56, 481, 1956.
27. 2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics 60, 655, 1977.
28. 2. Hospital Practice 11(6), 43, 1976;
29. 2 measurements. Crit. Care Med. 9, 689, 1981.
30. Peabody J. L., Gregory G. A., Willis M. M. and Tooley W. H. Transcutaneous oxygen tension in sick infants. Am. Rev. Resp. Dis. 118, 83, 1978.
31. Krauss A. N., Waldman S., Frayer W. W. and Auld P. A. M. Noninvasive estimation of arterial oxygenation in newborn infants. J. Pediatrics 93, 275, 1978.
32. 2 Monitors. Medical Devices Alert No. 73. Health and Welfare Canada, Health Protection Branch, 1985.
33. Department of Health and Social Security. Transcutaneous Oxygen Monitors. Hazard Notice. R/M1069/ 4493, DHSS Health Publications Unit, Nelson, 1980.
34. Rooth G., Huch A. and Huch R. Transcutaneous monitors are reliable indicators of arterial oxygen tension (if used correctly). Pediatrics 79, 283, 1987.
35. American Academy of Pediatrics, Task Force on Transcutaneous Oxygen Monitors. Report on consensus meeting, December 5-6, 1986. Pediatrics 83, 122, 1989.
36. Severinghaus J. W. and Astrup P. History of Blood Gas Analysis. International Anesthesiology Clinics 25(4). Little Brown and Company, Boston, 1987.
37. Lucey J. F. and Dangman B. A reexamination of the role of oxygen in retrolental fibroplasia. Pediatrics 73, 82, 1984.
38. Bancalari E., Flynn J., Goldberg R. N., Bawol R., Cassady J., Schiffman J., Feuer W., Roberts J., Gilling D. and Sim E. Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics 79, 663, 1987.
39. Tremper K. K. and Shoemaker W. C. Transcutaneous oxygen monitoring of critically ill adults, with and without low flow shock. Crit. Care Med. 9, 706, 1981.
40. Silverman W. A. and Flynn J. T. (Eds) Retinopathy of Prematurity. Blackwell Scientific Publications, Boston, 1985.
41. Jacobson R. M. and Feinstein A. R. Oxygen as a cause of blindness in premature infants: "Autopsy" of a decade of errors in clinical epidemiologic research. J. Clin. Epidemiol. 45, 1265, 1992.
42. Lucey J. F. Growth and development of transcutaneous monitoring in the U.S.A. - 1978-1986. In Continuous Transcutaneous Monitoring. Advances in Experimental Medicine and Biology (Edited by Huch A., Huch R. and Rooth G.), Vol. 220, pp. 19-21. Plenum Press, New York, 1987.
43. Flynn J. T., Bancalari E., Snyder E. S., Goldberg R. N., Feuer W., Cassady J., Schiffman J., Feldman H. I., Bachynski B., Buckley E., Roberts J. and Gillings D. A cohort study of transcutaneous tension and the incidence and severity of retinopathy of prematurity. N. Engl. J. Med. 326, 1050, 1992. Phelps D. L. Retinopathy of Prematurity 326, 1078, 1992.
44. Flynn J. T., Bancalari E., Snyder E. S., Goldberg R. N., Feuer W., Cassady J., Schiffman J., Feldman H. I., Bachynski B., Buckley E., Roberts J. and Gillings D. A cohort study of transcutaneous tension and the incidence and severity of retinopathy of prematurity. N. Engl. J. Med. 326, 1050, 1992. Phelps D. L. Retinopathy of Prematurity 326, 1078, 1992.
45. Rodriguez L. R., Kotin N., Lowenthal D. and Kattan M. A study of pediatric house staff's knowledge of pulse oximetry. Pediatrics 93, 810, 1994.
46. Reiser S. J. Medicine and the Reign of Technology. Cambridge University Press, New York, 1978.
47. Fineberg H. Effects of clinical evaluation on the diffusion of medical technology. In Institute of Medicine. Assessing Medical Technologies. National Academy Press, Washington, DC, 1985.
48. Unger S. H. Controlling Technology: Ethics and the Responsible Engineer. Holt, Rinehart and Winston, New York, 1982.
49. Miké V. Ethics, evidence, and uncertainty. Controlled Clin. Trials 11, 153, 1990.
50. Miké V. Understanding uncertainties in medical evidence: professional and public responsibilities. In Acceptable Evidence: Science and Values in Risk Management (Edited by Mayo D. G. and Hollander R. D.), pp. 115-136. Oxford University Press, New York, 1991.
51. Krauss A. N., Miké V. and Ross G. S. Perinatal technology: answers and questions. J. Clin. Ethics 3, 56, 1992.